Ondax Scientific has been involved over the last few years in a multinational clinical trial to evaluate the treatment of dogs with mitral valve disease. Results from the study showed that the administration of Pimobendan to dogs diagnosed with early stages of the disease can delay the onset of Heart Failure on average by 15 months compared with dogs treated with Placebo. Results from the study were recently published in the Journal of Veterinary Internal Medicine and the British press (The Times- 28Oct2016).
|Page: 1 of 5|
If you require additional information on any of ONDAX Scientific activities and services, please do not hesitate to contact us